ALI SHWAIKI, MD
Medical Oncology Physician in MERRIAM, Kansas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
ALI SHWAIKI, MD filed 507 Medicare Part D claims in 2023 as a Medical Oncology Physician in MERRIAM, Kansas, prescribing 84% generic.
- 507
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
ALI SHWAIKI, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
507 Top 34% higher than 66% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
ALI SHWAIKI, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about ALI SHWAIKI, MD?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Kansas
How Medical Oncology Physician compares to other specialties among Kansas providers
Medical Oncology Physician share within Kansas
Medical Oncology Physician is one of the more visible NUCC categories in Kansas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Medical Oncology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Medical Oncology Physician ABMS/AOA estimate
Est. board-certified rate (Medical Oncology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Medical Oncology Physician US NPIs
Specialty board-certified rate — Medical Oncology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
ALI SHWAIKI, MD appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD credentials at 9100 W 74TH ST, MERRIAM, KS, 66204, with a listed phone of (913) 632-9100. NPI 1407802895 was issued on 05/26/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SHWAIKI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 507 prescription claims written by this provider, covering 154 Medicare beneficiaries and totaling roughly $543K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 8.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Medical Oncology Physician is a narrow specialty nationwide, with 3,792 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1407802895 |
|---|---|
| Specialty | Medical Oncology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 05/26/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm ALI SHWAIKI, MD's current license status, disciplinary history, and board certifications with the Kansas Board of Healing Arts in Kansas before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where ALI SHWAIKI, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ALI SHWAIKI, MD. Source: openpaymentsdata.cms.gov.
Total received
$403
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
16% brand-name claims vs 84% generic, on 507 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 826
- Total Day Supply
- 22,379
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $530K
- Generic Drug Cost
- $13K
- Opioid Claims
- 43 (8.5% rate)
- Antibiotic Claims
- 33
Patient Demographics
- Average Patient Age
- 74.3 years
- Avg HCC Risk Score
- 1.36
- Gender Split
- 73% female / 27% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What ALI SHWAIKI, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Anastrozole
Anastrozole
91 claims
- Letrozole
Letrozole
44 claims
- Eliquis
Eliquis
41 claims
- Ondansetron Hcl 23
Ondansetron Hcl
23 claims
- Potassium Chloride 19
Potassium Chloride
19 claims
- Acyclovir 17
Acyclovir
17 claims
- Oxycodone Hcl 17
Oxycodone Hcl
17 claims
- Tamoxifen Citrate 17
Tamoxifen Citrate
17 claims
| Drug | Claims |
|---|---|
| Anastrozole | 91 |
| Letrozole | 44 |
| Eliquis Apixaban | 41 |
| Ondansetron Hcl | 23 |
| Potassium Chloride | 19 |
| Acyclovir | 17 |
| Oxycodone Hcl | 17 |
| Tamoxifen Citrate | 17 |
| Revlimid Lenalidomide | 14 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 13 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Medical Oncology Physician Overview
How ALI SHWAIKI, MD fits within the Medical Oncology Physician landscape nationally.
ALI SHWAIKI, MD's 507 claims are below the specialty average of 689.
Nearby Medical Oncology Physician Providers in Kansas
Other clinicians with the same primary specialty enrolled in Kansas, drawn from the same CMS NPPES roster as SHWAIKI.
Compare Medical Oncology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Kansas
Frequently Asked Questions
What is ALI SHWAIKI, MD's specialty? ▼
How much does ALI SHWAIKI, MD prescribe under Medicare Part D? ▼
Where is ALI SHWAIKI, MD located? ▼
What is ALI SHWAIKI, MD's NPI number? ▼
Does ALI SHWAIKI, MD prescribe more brand-name or generic drugs? ▼
Does ALI SHWAIKI, MD prescribe opioids? ▼
How many Medical Oncology Physician providers are there in the US? ▼
What drugs does ALI SHWAIKI, MD prescribe most often? ▼
Does ALI SHWAIKI, MD accept Medicare? ▼
How can I verify ALI SHWAIKI, MD's credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology